1. Significant associations between driver gene mutations and DNA methylation alterations across many cancer types
   Yun-Ching Chen et al, 2017, PLOS Computational Biology CrossRef
2. A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements
   Marie Jarosova et al, 2016, Pathology & Oncology Research CrossRef
3. RasGrf1 and RasGrf2
   Eugenio Santos et al, 2018, Encyclopedia of Signaling Molecules CrossRef
4. Amplification of B cell receptor–Erk signaling by Rasgrf-1 overexpression in chronic lymphocytic leukemia
   Wei Liao et al, 2014, Leukemia & Lymphoma CrossRef
5. Recent progress in targeted therapy for non-small cell lung cancer
   Yanxia Xiao et al, 2023, Frontiers in Pharmacology CrossRef
6. Fusion Oncogenes of Sarcomas
   Pierre Åman, 2015, Chromosomal Translocations and Genome Rearrangements in Cancer CrossRef
7. Costello Syndrome and Umbilical Ligament Rhabdomyosarcoma in Two Pediatric Patients: Case Reports and Review of the Literature
   Carlos Sánchez-Montenegro et al, 2017, Case Reports in Genetics CrossRef
8. Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo
   Maciej Tarnowski et al, 2017, BMC Cancer CrossRef
9. MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes
   Shilpa S. Dhar et al, 2018, Molecular Cell CrossRef
10. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells
    Marta Tkacz et al, 2022, Diagnostics CrossRef
11. RasGrf1 and RasGrf2
    Eugenio Santos et al, 2016, Encyclopedia of Signaling Molecules CrossRef
12. Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer
    Agnieszka A. Rucki et al, 2017, Cancer Research CrossRef
13. Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
    Baihui Li et al, 2021, Neoplasia CrossRef
14. 5-Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulin-like growth factor 2 expression and reactivating the H19 gene product miR-675, which negatively affects insulin-like growth factors and insulin signaling
    MACIEJ TARNOWSKI et al, 2015, International Journal of Oncology CrossRef
15. miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1
    Danni Deng et al, 2016, Tumor Biology CrossRef
16. An eQTL analysis of the human glioblastoma multiforme genome
    Max Shpak et al, 2014, Genomics CrossRef
17. The Rat Sarcoma Virus (RAS) Family of Proteins in Sarcomas
    Beytullah Unat, 2024, Cureus CrossRef
18. Does it make sense to target one tumor cell chemotactic factor or its receptor when several chemotactic axes are involved in metastasis of the same cancer?
    Mariusz Z. Ratajczak et al, 2016, Clinical and Translational Medicine CrossRef
19. Effect of Ras-guanine nucleotide release factor 1-mediated H-Ras/ERK signaling pathway on glioma
    Yi-Heng Pan et al, 2021, Brain Research CrossRef